868 views4 min read
Mydecine Innovations Announces Closing of Prospectus Supplement Financing
VANCOUVER, British Columbia, Sept. 19, 2023 -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, is pleased to... Read More...